Registry study of lymphoma in people living with HIV
Collects data on treatment and outcomes in adults with HIV-related lymphoma.
Plain-language title generated from the registry record
Registry title: A Registry Study on HIV-related Lymphoma
Key facts
- Where
- Amsterdam, NetherlandsSee the site
Where in Netherlands
- Amsterdam University Medical CentersAmsterdam, NetherlandsNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Rotkreuzklinikum München gGmbH
- Trial code
- NCT05231135
- Record updated
- 6 April 2023
- Original description
Retrospective und prospective registry on HIV-associated lymphoma. Data on characteristics, type and toxicity of treatment and outcome of patients with HIV-lymphoma will be collected.Read full original descriptionShow less
Characteristics, Treatment and Outcomes of HIV-infected Patients With Malignant Lymphoma: A Registry Study of the European Hematology Association (EHA) Lymphoma Group
Retrospective und prospective registry on HIV-associated lymphoma. Data on characteristics, type and toxicity of treatment and outcome of patients with HIV-lymphoma will be collected.
Inclusion: Histology or cytology proven non-Hodgkin lymphoma or Hodgkin lymphoma; HIV-infection at time of lymphoma diagnosis; Lymphoma diagnosis since 01.01.2010; Adult patients ≥ 18 years; Written informed consent.
Exclusion: HIV-diagnosis > 3 months after the diagnosis of malignant lymphoma; Non-Compliance or lack of opportunity for follow-up (for the prospective part of the study).